Piotr Ponikowski
Overview
Explore the profile of Piotr Ponikowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
870
Citations
52148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cotter G, Davison B, Biegus J, Pagnesi M, Metra M, Butler J, et al.
J Card Fail
. 2025 Feb;
PMID: 39947427
No abstract available.
12.
Ivey-Miranda J, Rao V, Shaburishvili T, Verulava I, Khabeishvili N, Petrie M, et al.
J Card Fail
. 2025 Feb;
PMID: 39947422
No abstract available.
13.
Davison B, Abbate A, Cotter G, Pascual-Figal D, Van Tassell B, Villota J, et al.
Heart Fail Rev
. 2025 Feb;
PMID: 39939545
We examined current evidence regarding the effects of anti-inflammatory therapies in patients with acute heart failure (AHF) on the risk of cardiovascular outcomes, inflammatory markers, natriuretic peptides, and renal function....
14.
Damasceno A, Saidu H, Cotter G, Davison B, Edwards C, Celutkiene J, et al.
ESC Heart Fail
. 2025 Feb;
PMID: 39938529
Aims: Acute heart failure (AHF) impacts millions globally, with outcomes varying based on socio-economic status (SES). Methods: SES measured by annual household income, years of education and medical insurance coverage....
15.
Pagnesi M, Cotter G, Davison B, Freund Y, Voors A, Edwards C, et al.
ESC Heart Fail
. 2025 Feb;
PMID: 39934967
Aims: Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health-related quality of life (QoL)...
16.
Yang M, Kondo T, Talebi A, Jhund P, Docherty K, Claggett B, et al.
JACC Heart Fail
. 2025 Feb;
13(2):277-292.
PMID: 39909641
Background: The value of generic quality of life (QoL) instruments in heart failure (HF) is uncertain. Objectives: In this study, the authors sought to quantify individual dimension scores and the...
17.
Vitale C, Berthelot E, Coats A, Loreena H, Albert N, Tkaczyszyn M, et al.
ESC Heart Fail
. 2025 Feb;
PMID: 39904922
Aims: The Heart Failure Frailty Score (HFFS) is a novel, multidimensional tool to assess frailty in patients with heart failure (HF). It has been developed to overcome limitations of existing...
18.
Salah H, Ebner A, Srinivasa R, Pabon-Ramos W, Beecham Chick J, Biegus J, et al.
J Cardiovasc Transl Res
. 2025 Feb;
PMID: 39900887
Lymphatic dysfunction contributes to congestion and end-organ damage in heart failure (HF), yet current therapies do not directly target lymphatic congestion. Thoracic duct (TD) drainage offers a novel approach to...
19.
Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial
Ezekowitz J, Mulder H, Mentz R, Butler J, DE Pasquale C, Lewis G, et al.
J Card Fail
. 2025 Jan;
PMID: 39890013
Background: The HEART-FID trial (Randomized Placebo-Controlled Trial of Ferric Carboxymaltose [FCM] as Treatment for Heart Failure with Iron Deficiency) is the largest trial to test intravenous iron (ferric carboxymaltose [FCM])...
20.
Anker S, Friede T, Butler J, Talha K, Diek M, Nosko A, et al.
Eur J Heart Fail
. 2025 Jan;
PMID: 39876699
Aims: While it is widely accepted that intravenous (IV) iron improves functional capacity, symptoms, and cardiovascular outcomes in patients with heart failure (HF) with reduced ejection fraction (HFrEF) diagnosed with...